In their recent debt to equity, they set a minimum conversion price of 0.002. Which means the company thinks the share price could go there and to 0.001, otherwise why bother setting this floor?
- Forums
- ASX - By Stock
- ME1
- Ann: Halucenex Phase II Clinical Trial Update
Ann: Halucenex Phase II Clinical Trial Update, page-13
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ME1 (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
-0.013(32.5%) |
Mkt cap ! $1.276M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 2.3¢ | $137.0K | 4.400M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 110297 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 8719 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 364 | 0.027 |
1 | 60000 | 0.026 |
3 | 139347 | 0.025 |
6 | 161777 | 0.024 |
4 | 209520 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 8719 | 2 |
0.030 | 50000 | 1 |
0.035 | 157853 | 2 |
0.037 | 31386 | 1 |
0.040 | 24667 | 2 |
Last trade - 13.07pm 19/06/2024 (20 minute delay) ? |
Featured News
ME1 (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online